Listar por autor "Díaz Navarro, Ander"

Repositorio

Cómo publicar

Recursos

FAQs

Mostrando ítems 1-14 de 14

Analysis of extracellular matrix network dynamics in cancer using the Matrinet database

Kontio, J.; Soñora, V. R.; Pesola, V.; Lamba, R.; Dittmann, A.; Díaz Navarro, Ander; Koivunen, J.; Pihlajaniemi, T.; Izzi, V. (2022)
Chromosome 12p amplification in triple-negative/BRCA1-mutated breast cancer associates with emergence of docetaxel resistance and carboplatin sensitivity

Gomez-Miragaya, J.; Díaz Navarro, Ander; Tonda, R.; Beltran, S.; Palomero, L.; Palafox, M.; Dobrolecki, L. E.; Huang, C.; Vasaikar, S.; Zhang, B.; Wulf, G. M.; Collado-Sole, A.; Trinidad, E. M.; Muñoz, P.; Pare, L.; Prat, A.; Bruna, A.; Caldas, C.; Arribas, J.; Soler-Monso, M.T.; Petit, A.; Balmaña, J.; Suárez Puente, Xosé Antón (2019)
Circulating tumour DNA from the cerebrospinal fluid allows the characterisation and monitoring of medulloblastoma

Escudero, L.; Llort, A.; Arias, A.; Díaz Navarro, Ander; Martínez Ricarte, F.; Rubio Pérez, C.; Mayor, R.; Caratù, G.; Martínez Sáez, E.; Vázquez Méndez, É.; Lesende Rodríguez, I.; Hladun, R.; Gros, L.; Ramón y Cajal, S.; Poca, M. A.; Suárez Puente, Xosé Antón (2020)
Development of a tool for the identification of somatic mutations and analysis of non-coding mutations in cancer

Díaz Navarro, Ander (2022-07-22)
Dissecting degradomes: Analysis of protease-coding genes

Álvarez Eguiluz, Ángel; Díaz Navarro, Ander; Suárez Puente, Xosé Antón (2018)
Featuring brca1 and brca2 germline mutational landscape from Asturias (north Spain)

Sánchez Pitiot, Ana; Blay, P.; Díaz Navarro, Ander; Fernández Arrojo, Sara; Romero, R.; Álvarez Eguiluz, Ángel; Alvarado, M. G.; Álvarez, N.; García Teijido, P.; Fernández, Y.; Palacio, I.; Suárez Puente, Xosé Antón; Balbín Felechosa, Milagros (2024)
Genomic and Epigenomic Alterations in Chronic Lymphocytic Leukemia

Nadeu, F.; Díaz Navarro, Ander; Delgado, J.; Suárez Puente, Xosé Antón; Campo, E. (2020)
Genomic and epigenomic insights into the origin, pathogenesis, and clinical behavior of mantle cell lymphoma subtypes

Nadeu, Ferrán; Martín García, David; Clot, Guillem; Díaz Navarro, Ander (2020)
Molecular map of chronic lymphocytic leukemia and its impact on outcome

Knisbacher, B. A.; Lin, Z.; Hahn, C. K.; Bousquets Muñoz, Pablo; Díaz Navarro, Ander; López Tamargo, Sara; Suárez Puente, Xosé Antón (2022)
Pancancer analysis of somatic mutations in repetitive regions reveals recurrent mutations in snRNA U2

Bousquets Muñoz, Pablo; Díaz Navarro, Ander; Nadeu, F.; Sánchez Pitiot, Ana; López Tamargo, Sara; Shuai, S.; Balbín, M.; Tubio, J. M. C.; Beà, S.; Martin Subero, J. I.; Gutiérrez Fernández, Ana Yolanda; Stein, L. D.; Campo, E.; Suárez Puente, Xosé Antón (2022)
Recurrent noncoding U1 snRNA mutations drive cryptic splicing in SHH medulloblastoma

Suzuki, H.; Kumar, S. A.; Shuai, S.; Díaz Navarro, Ander; Suárez Puente, Xosé Antón (2019)
Rfcaller: a machine Learning approach combined with read-level features to detect somatic mutations

Díaz Navarro, Ander; Bousquets Muñoz, Pablo; Nadeu, F.; López Tamargo, Sara; Beà, S.; Campo, E.; Suárez Puente, Xosé Antón (2023)
The U1 spliceosomal RNA is recurrently mutated in multiple cancers

Shuai, Shimin; Suzuki, Hiromichi; Díaz Navarro, Ander; Nadeu, Ferran; Gutiérrez Fernández, Ana Yolanda; López Otín, Carlos (2019)
Tumor xenograft modeling identifies an association between TCF4 loss and breast cancer chemoresistance

Ruiz de Garibay, Gorka; Mateo, Francesca; Stradella, Agostina; Álvarez Puente, Diana; Díaz Navarro, Ander; Suárez Puente, Xosé Antón (2018)

Listar por autor "Díaz Navarro, Ander"

Analysis of extracellular matrix network dynamics in cancer using the Matrinet database ﻿

Chromosome 12p amplification in triple-negative/BRCA1-mutated breast cancer associates with emergence of docetaxel resistance and carboplatin sensitivity ﻿

Circulating tumour DNA from the cerebrospinal fluid allows the characterisation and monitoring of medulloblastoma ﻿

Development of a tool for the identification of somatic mutations and analysis of non-coding mutations in cancer ﻿

Dissecting degradomes: Analysis of protease-coding genes ﻿

Featuring brca1 and brca2 germline mutational landscape from Asturias (north Spain) ﻿

Genomic and Epigenomic Alterations in Chronic Lymphocytic Leukemia ﻿

Genomic and epigenomic insights into the origin, pathogenesis, and clinical behavior of mantle cell lymphoma subtypes ﻿

Molecular map of chronic lymphocytic leukemia and its impact on outcome ﻿

Pancancer analysis of somatic mutations in repetitive regions reveals recurrent mutations in snRNA U2 ﻿

Recurrent noncoding U1 snRNA mutations drive cryptic splicing in SHH medulloblastoma ﻿

Rfcaller: a machine Learning approach combined with read-level features to detect somatic mutations ﻿

The U1 spliceosomal RNA is recurrently mutated in multiple cancers ﻿

Tumor xenograft modeling identifies an association between TCF4 loss and breast cancer chemoresistance ﻿

Analysis of extracellular matrix network dynamics in cancer using the Matrinet database

Chromosome 12p amplification in triple-negative/BRCA1-mutated breast cancer associates with emergence of docetaxel resistance and carboplatin sensitivity

Circulating tumour DNA from the cerebrospinal fluid allows the characterisation and monitoring of medulloblastoma

Development of a tool for the identification of somatic mutations and analysis of non-coding mutations in cancer

Dissecting degradomes: Analysis of protease-coding genes

Featuring brca1 and brca2 germline mutational landscape from Asturias (north Spain)

Genomic and Epigenomic Alterations in Chronic Lymphocytic Leukemia

Genomic and epigenomic insights into the origin, pathogenesis, and clinical behavior of mantle cell lymphoma subtypes

Molecular map of chronic lymphocytic leukemia and its impact on outcome

Pancancer analysis of somatic mutations in repetitive regions reveals recurrent mutations in snRNA U2

Recurrent noncoding U1 snRNA mutations drive cryptic splicing in SHH medulloblastoma

Rfcaller: a machine Learning approach combined with read-level features to detect somatic mutations

The U1 spliceosomal RNA is recurrently mutated in multiple cancers

Tumor xenograft modeling identifies an association between TCF4 loss and breast cancer chemoresistance